Macquarie buys Merrill's Australian instalment warrants business

Australia's Macquarie Bank has purchased the instalment warrants business of Merrill Lynch following the restructuring of the US bank's Australian operations.

Instalment warrants effectively allow an investor the right to buy an underlying share through several 'instalments'. The issue price is usually around 20-50% of the underlying share, and gives the investor the right to receive dividends during the life of the warrant. At maturity, investors can either pay the remaining value and obtain the shares, or let the warrant expire.

Macquarie will take responsibility for market making, provision of loan facilities and risk management of existing Merrill Lynch instalments warrants. "We will provide Merrill Lynch clients with the same high level of service Macquarie Instalments clients enjoy," said Mark Small, division director in Macquarie's warrant business.

The warrants market continues to grow in Australia, with the Australian Stock Exchange (ASX) figures indicating the total value of warrants traded will exceed A$3 billion ($1.6 billion) in calendar year 2002. "We expect the value of Macquarie warrant product traded on the ASX this tear to be 40% higher than last year," added Small.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

What gold's rise means for rates, equities

It has been several years since we have seen volatility in gold. An increase in gold volatility can typically be associated with a change in sentiment and investor behavior. The precious metal has surged this year on increased demand for safe haven…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here